Stay updated on Pembrolizumab for Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Biliary Tract Cancer Clinical Trial page
- Check5 days agoChange DetectedFooter now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing v3.3.1; no observable changes to study content, endpoints, contacts, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing Revision: v3.2.0; this is a minor software/version update with no observable changes to study information or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved the generic government funding status notice from the page header; this change does not affect the study details, eligibility criteria, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedNo significant changes detected; the Study Details page content appears unchanged between versions.SummaryDifference0.4%

- Check84 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

Stay in the know with updates to Pembrolizumab for Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.